Search Within

Nicholas Mai

Formats
  1. Meeting Abstract (6)
  2. Journal Article (4)
  3. Review (1)
Groups
  1. Department of Medicine (11)
  2. GME, Medicine (11)
  3. Graduate Medical Education (11)
  4. Hematology-Oncology Fellows (11)
  5. Solid Tumor Oncology Division (11)
  6. Breast Medicine Service (10)

More Groups

People
  1. Sarat Chandarlapaty (7)
  2. Yuan Chen (7)
  3. Pedram Razavi (6)
  4. Anton Safonov (4)
  5. Joshua Drago (4)
  6. Mark Robson (4)

More People

Years
  1. 2025 (4)
  2. 2024 (6)
  3. 2023 (1)
Publications
  1. Journal of Clinical Oncology (6)
  2. npj Breast Cancer (2)
  3. Clinical Breast Cancer (1)
  4. JCO Precision Oncology (1)
  5. npj Precision Oncology (1)
Publishers
  1. American Society of Clinical Oncology (7)
  2. Nature Publishing Group (2)
  3. Elsevier Inc. (1)
  4. Springer Nature (1)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Timing of neoadjuvant pembrolizumab infusion and pathologic complete response among patients with triple-negative breast cancer receiving the KEYNOTE-522 regimen
    Meeting Abstract

    Shen, S.; Myers, S.; Polidorio, N.; Bromberg, M.; Chen, Y.; Tan, R.; Mai, N.; Abuhadra, N.; Traina, T. A.; Downs-Canner, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Ultrasensitive ctDNA monitoring during CDK4/6 inhibitor therapy for metastatic breast cancer
    Meeting Abstract

    Ah-Reum An, J.; Jasper, J.; Cabel, L.; Yildirim, S. Y.; da Silva, E. M.; Patel, R. K.; LaBella, M.; Teysir, J.; Mai, N.; Safonov, A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Effect of ERBB2 activating mutations on enhanced internalization and activity of trastuzumab deruxtecan in HER2-non-amplified metastatic breast cancer
    Meeting Abstract

    Mai, N.; Liu, B.; Safonov, A.; Shen, S.; Zelizer, S.; White, C.; Chen, Y.; Razavi, P.; Jhaveri, K. L.; Modi, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Sequential antibody-drug conjugate therapy in patients with metastatic breast cancer treated with sacituzumab govitecan and trastuzumab deruxtecan
    Journal Article

    Mai, N.; Lieberman, M. M. K.; Ferraro, E.; Bromberg, M.; Chen, Y.; Razavi, P.; Modi, S.; Chandarlapaty, S.; Walsh, E. M.; Drago, J. Z.
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Predictors of response to CDK4/6i retrial after prior CDK4/6i failure in ER+ metastatic breast cancer
    Journal Article

    Mai, N.; dos Anjos, C. H.; Razavi, P.; Safonov, A.; Patil, S.; Chen, Y.; Drago, J. Z.; Modi, S.; Bromberg, J. F.; Dang, C. T.; more...
    npj Breast Cancer (2024)

    Fulltext@MSK | Save
  • Preliminary results from FLAGSHP-1: A phase 1 study of ERAS-601 as a monotherapy or in combination with cetuximab in patients (pts) previously treated for advanced chordoma
    Meeting Abstract

    Gounder, M. M.; Rosen, E.; Parikh, A. R.; Conley, A. P.; Hong, D. S.; Sheth, S.; Mai, N.; Sgroe, E.; Mitchell, R.; Picard, R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Real world outcomes of sequential ADC therapy in metastatic breast cancer: Patients treated with sacituzumab govitecan and trastuzumab deruxtecan
    Meeting Abstract

    Mai, N.; Klar, M.; Ferraro, E.; Bromberg, M.; Chen, Y.; Razavi, P.; Modi, S.; Chandarlapaty, S.; Walsh, E. M.; Drago, J. Z.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Immune checkpoint inhibition for the treatment of metastatic breast cancer with high tumor mutational burden: Real world clinical and genomic correlates of response
    Meeting Abstract

    Mai, N.; Safonov, A.; Marra, A.; Chen, Y.; Chandarlapaty, S.; Razavi, P.; Plitas, G.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Pathologic complete response to KEYNOTE522 and HER2-directed therapy for synchronous TNBC and HER2+ breast cancer
    Journal Article

    Mai, N.; Chen, J. F.; Rana, S.; Robson, M.; Chandarlapaty, S.; Rosen, E. Y.
    npj Precision Oncology (2024)

    Fulltext@MSK | Save
  • Dose dense doxorubicin plus cyclophosphamide in a modified KEYNOTE522 regimen for triple negative breast cancer
    Journal Article

    Mai, N.; Myers, S.; Shen, S.; Downs-Canner, S.; Robson, M.; Norton, L.; Chen, Y.; Traina, T.; Abuhadra, N.
    npj Breast Cancer (2024)

    Fulltext@MSK | Save